Literature DB >> 12746470

Crescentic glomerulonephritis and subepidermal blisters with autoantibodies to alpha5 and alpha6 chains of type IV collagen.

Reza F Ghohestani1, Sherry L Rotunda, Billy Hudson, William J Gaughan, John L Farber, Guy Webster, Jouni Uitto.   

Abstract

We describe a novel autoimmune disease characterized by severe subepidermal bullous eruption and crescentic glomerulonephritis with autoantibodies directed against the noncollagenous domain of the alpha5 and alpha6 chains of type IV collagen. Biopsy of perilesional skin revealed a subepidermal blister with marked polymorphonuclear infiltrate with linear deposits of IgA and C3. Light microscopy of a kidney biopsy specimen revealed a crescentic glomerulonephritis, and immunofluorescence microscopy showed linear basement membrane staining for IgA (3+), C3 (1+), and IgG (1+). No electron-dense deposits were observed by transmission electron microscopy. The patient's autoantibodies reacted with normal human skin and kidney: IgA (3+) and IgG (1+) antibodies stained the basement membrane zones of skin, renal glomerulus, and some tubules. The identity of the target antigen was determined by immunochemical analyses of candidate antigens using the patient's autoantibodies. The patient's IgA and IgG autoantibodies reacted with a 185- to 190-kDa antigen from a human dermal extract that was distinguished from the other dermal or epidermal antigens, including the 145- to 290-kDa (type VII collagen) epidermolysis bullosa acquisita antigen, the 165- to 200-kDa alpha3 laminin mucous membrane cicatricial pemphigoid antigen, and the 230-kDa and the 180-kDa bullous pemphigoid antigens. Patient's IgA and IgG autoantibodies further reacted with the alpha5(IV) and weakly with the alpha6(IV) chains of type IV collagen by Western blot and ELISA. This report expands the repertoire of bullous skin disorders and provides an explanation for the association of anti-type IV collagen autoantibodies and glomerulonephritis with subepidermal blisters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746470     DOI: 10.1097/01.lab.0000067497.86646.4d

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

Review 1.  Minor collagens of the skin with not so minor functions.

Authors:  Georgios Theocharidis; John T Connelly
Journal:  J Anat       Date:  2017-02-02       Impact factor: 2.610

Review 2.  Basement membranes and autoimmune diseases.

Authors:  Mary H Foster
Journal:  Matrix Biol       Date:  2016-08-02       Impact factor: 11.583

Review 3.  Advances in human antiglomerular basement membrane disease.

Authors:  Zhao Cui; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

Review 4.  An unusual case of IgA-mediated anti-glomerular basement membrane disease.

Authors:  Yao-Ko Wen; Kai-I Wen
Journal:  Int Urol Nephrol       Date:  2012-03-29       Impact factor: 2.370

5.  Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.

Authors:  Zhao Cui; Ming-Hui Zhao; Xiao-Yu Jia; Miao Wang; Shui-Yi Hu; Su-Xia Wang; Feng Yu; Kyle L Brown; Billy G Hudson; Vadim Pedchenko
Journal:  J Autoimmun       Date:  2016-04-23       Impact factor: 7.094

6.  Antigenic heterogeneity of IgA anti-GBM disease: new renal targets of IgA autoantibodies.

Authors:  Julie Ho; Ian W Gibson; James Zacharias; Fernando Fervenza; Selene Colon; Dorin-Bogdan Borza
Journal:  Am J Kidney Dis       Date:  2008-08-26       Impact factor: 8.860

7.  Collagen IV in Normal Skin and in Pathological Processes.

Authors:  Ana Maria Abreu-Velez; Michael S Howard
Journal:  N Am J Med Sci       Date:  2012-01

8.  IgA-mediated anti-glomerular basement membrane disease: an uncommon mechanism of Goodpasture's syndrome.

Authors:  Guillaume Moulis; Antoine Huart; Joëlle Guitard; Françoise Fortenfant; Dominique Chauveau
Journal:  Clin Kidney J       Date:  2012-10-18

9.  Suppression of collagen IV alpha-2 subunit by prolyl hydroxylase domain inhibition via hypoxia-inducible factor-1 in chronic kidney disease.

Authors:  Mohammad Sanaei-Ardekani; Shyreen Kamal; Whitney Handy; Sidrah Alam; Aya Salaheldin; Anderson Moore; Shahrzad Movafagh
Journal:  Pharmacol Res Perspect       Date:  2021-10

10.  Binding Truths: Atypical Anti-Glomerular Basement Membrane Disease Mediated by IgA Anti-Glomerular Basement Membrane Antibodies Targeting the α1 Chain of Type IV Collagen.

Authors:  Marilina Antonelou; Scott R Henderson; Gurjeet Bhangal; Lauren Heptinstall; Ben Oliveira; Sally Hamour; Mark Harber; Alan D Salama
Journal:  Kidney Int Rep       Date:  2018-08-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.